Allspring Global Investments Holdings, LLC Prothena Corp Public LTD CO Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 73 shares of PRTA stock, worth $1,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1,735 95.79%

Holding current value

$1,321

Previous $35,000 97.14%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$16.73 - $24.79 $27,805 - $41,200	-1,662 Reduced 95.79%	73 $1,000
Q2 2024 Jul 26, 2024	SELL	$19.54 - $26.15 $7,601 - $10,172	-389 Reduced 18.31%	1,735 $35,000
Q1 2024 Apr 18, 2024	BUY	$24.75 - $40.66 $4,380 - $7,196	177 Added 9.09%	2,124 $52,000
Q4 2023 Jan 25, 2024	SELL	$32.31 - $52.32 $37,124 - $60,115	-1,149 Reduced 37.11%	1,947 $70,000
Q3 2023 Oct 27, 2023	BUY	$47.3 - $70.6 $146,440 - $218,577	3,096 New	3,096 $149,000
Q2 2023 Jul 18, 2023	SELL	$48.26 - $78.59 $148,158 - $241,271	-3,070 Reduced 61.08%	1,956 $133,000
Q1 2023 Apr 13, 2023	SELL	$46.97 - $58.27 $91,967 - $114,092	-1,958 Reduced 28.04%	5,026 $243,000
Q4 2022 Jan 23, 2023	SELL	$52.05 - $65.0 $300,484 - $375,245	-5,773 Reduced 45.25%	6,984 $421 Million
Q3 2022 Oct 26, 2022	SELL	$25.16 - $60.63 $8,831 - $21,281	-351 Reduced 2.68%	12,757 $773,000
Q2 2022 Jul 25, 2022	SELL	$22.73 - $39.98 $288,466 - $507,386	-12,691 Reduced 49.19%	13,108 $355,000
Q1 2022 May 02, 2022	SELL	$30.27 - $49.22 $2.17 Million - $3.52 Million	-71,533 Reduced 73.49%	25,799 $943,000
Q4 2021 Jan 28, 2022	BUY	$42.11 - $73.26 $4.1 Million - $7.13 Million	97,332 New	97,332 $4.81 Million

Others Institutions Holding PRTA

# of Institutions

179

Shares Held

42.8M

Call Options Held

77.7K

Put Options Held

92.7K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $849M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Prothena Corp Public LTD CO Transaction History